2023 is a special year for our company: Biotechgate is celebrating its 20th anniversary. Since the launch of its first database in Switzerland in 2003, Biotechgate has continuously evolved into the largest business development and licensing database unique to the life sciences sector. Today, subscribers can explore over 66,000 companies, 760,000 clinical trials, and 27,000 … Continue reading Celebrating 20 years of Biotechgate
Category: Publications & News
In this chapter we publish articles about Biotechgate as well as Biotech related topics. Also most of the articles published in newsletters are available here.
Diagnostics: Industry Trends for 2023
The diagnostics industry has been the subject of increased attention since the emergence of COVID-19, with the market currently estimated at USD 23.2 billion in 2022 and projected to grow 5.4% by 2027 to reach a value of USD 30.2 billion. Here, we discuss three trends that are believed to have an impact on the … Continue reading Diagnostics: Industry Trends for 2023
Building a Strong Relationship with Management
The dynamic between the board of directors and executive leadership is often taken for granted, but plays a key role for the success of a biotechnology company. In a biotech start-up that fuses commercial and scientific functions, it is crucial for the decision-making process in the boardroom to be well-balanced; the executive team – especially … Continue reading Building a Strong Relationship with Management
The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)
Despite 2022 being a relatively quiet year for M&A activity within the biopharma space, especially when compared to 2021, a number of prominent deals have taken place. Find out the 8 largest M&A deals of the year so far in order of the total amount. 8. Zogenix Acquired by: UCB Amount: USD 1.9bn After Zogenix’s … Continue reading The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)
Current Trends in M&A Activity
In terms of M&A activity, 2022 is a rather quiet year so far compared to record-breaking year 2021 when private equity investments boomed. In this article, read about recent trends and an outlook on M&A deals in the life science industry. Upswing in biopharma M&As in Q2 2022 According to a report by J.P. Morgan, … Continue reading Current Trends in M&A Activity
Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio
Biotechgate is in close partnership with the Maryland Department of Commerce. In an interview with Ulyana Desiderio, the Director of the Department’s Office of Life Science, she tells Biotechgate about her experience with the partnership and her work in the state’s life science ecosystem. Ulyana Desiderio is Director of the Office of Life Science at … Continue reading Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio
The Current State of Therapeutics Financing: Trends in Public Market
Last month’s article on private equity therapeutics financing trends showed how biotech start-ups struggle to raise private equity investment this year, following the pandemic-driven life sciences boom. In this article, we will take a closer look at how recent challenges are reflected in the IPO market and outline public financing trends. In the wake of … Continue reading The Current State of Therapeutics Financing: Trends in Public Market
Finding Financial Information in Biotechgate
With over 1.3 million total entries, the Biotechgate Business Development and Investor databases serve as your primary source of information relating to the life science industry. This allows you to have access to data on organizations from start-ups right through to well-established multinationals and everything in between. Read on for an overview of the financial … Continue reading Finding Financial Information in Biotechgate
The 10 Largest Life Science IPOs (January – July, 2022)
IPOs serve as the lifeblood of the life science industry, allowing companies access to a vast source of capital that can fund their R&D activities and give previous investors a return on their initial financing. In 2022, there has been a noted contraction in the performance of life science IPOs which, in turn, has caused … Continue reading The 10 Largest Life Science IPOs (January – July, 2022)
The Current State of Therapeutics Financing: Trends in Private Equity Investment
The global pandemic generated record investments in life science companies back in 2020 and 2021, when growth was largely driven by development of COVID-19 vaccines and drugs that helped overcome the acute phase of the pandemic. However, in 2022 the war in Ukraine has led to macroeconomic changes that causes the financial environment for the … Continue reading The Current State of Therapeutics Financing: Trends in Private Equity Investment